PEOPLE - MediSpectra makes appointment:
This article was originally published in Clinica
MediSpectra has appointed Dr James Myrtle as vice-president of clinical affairs. Prior to joining the US developer of non-contact optical biopsy systems, Dr Myrtle had held various positions in Chiron Diagnostics, Boehringer Mannheim, and SmithKline Clinical Labs.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.